Vaccination: Moderna's vaccine against the South African variant ready for clinical trials (Archives) -
USA Today Network / Sipa USA / SIPA
The American biotech company Moderna announced on Wednesday that a modified version of its anti-Covid vaccine, developed specifically against the South African variant, was ready to be tested in humans in clinical trials.
"Moderna has sent doses of its specific candidate vaccine against the variant (…) first identified in South Africa to the NIH (US National Institutes of Health), for a clinical study," the company said in a statement.
"As many modifications to our vaccine as necessary"
"In our fight against Covid-19, we must be vigilant and proactive about the new variants of SARS-CoV-2 that are emerging," added Stéphane Bancel, boss of Moderna.
"Moderna is committed to making as many changes to our vaccine as necessary, until the pandemic is under control," he continued.
The U.S. Medicines Agency said on Monday that manufacturers will not have to go through the lengthy authorization process again for already approved vaccines if they are changed to combat the emergence of new variants of the coronavirus. , which should greatly shorten the process.
Health
Coronavirus: More than 31,000 cases of contamination and 278 deaths in 24 hours
World
Vaccination in the United States: The authorities confirm the effectiveness of the Johnson & Johnson vaccine on severe forms
Covid 19
Anti-covid vaccine
Coronavirus
Society
Vaccination